Copeland Capital Management LLC acquired a new stake in CVS Health Co. (NYSE:CVS – Free Report) in the fourth quarter, Holdings Channel.com reports. The firm acquired 2,325 shares of the pharmacy operator’s stock, valued at approximately $104,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health during the third quarter valued at about $25,000. Ridgewood Investments LLC increased its holdings in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 450 shares during the period. Livelsberger Financial Advisory bought a new position in CVS Health in the 3rd quarter valued at $31,000. Legacy Investment Solutions LLC purchased a new position in shares of CVS Health during the 3rd quarter valued at $31,000. Finally, Reston Wealth Management LLC bought a new position in shares of CVS Health in the third quarter worth $32,000. Institutional investors own 80.66% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts recently commented on CVS shares. TD Cowen boosted their target price on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Piper Sandler lowered their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Truist Financial cut their price target on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research note on Monday, January 6th. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Finally, Mizuho reduced their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $68.12.
CVS Health Trading Down 0.5 %
Shares of CVS opened at $56.53 on Monday. The firm has a fifty day simple moving average of $51.24 and a two-hundred day simple moving average of $56.16. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The stock has a market capitalization of $71.13 billion, a P/E ratio of 14.35, a PEG ratio of 0.62 and a beta of 0.59. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.
CVS Health (NYSE:CVS – Get Free Report) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. During the same period last year, the firm earned $2.21 earnings per share. CVS Health’s quarterly revenue was up 6.3% on a year-over-year basis. On average, research analysts anticipate that CVS Health Co. will post 5.18 EPS for the current year.
CVS Health Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.71%. The ex-dividend date is Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
- Five stocks we like better than CVS Health
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- What is a SEC Filing?
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- The How and Why of Investing in Gold Stocks
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.